substack.com
From the blog:
There are many reasons why change for people with ME remains so elusive — many of them structural. But there’s one unavoidable fact that sits across it all: many of the changes we want — research funding, medical education, improvements to NHS services — cost money. And right now Britain is short of cash.
I’m not convinced that this is a very significant reason for lack of ME/CFS research funding. The largest grants for biomedical ME/CFS research have been for Decode and Sequence which have both been awarded when the UK Treasury has been struggling to balance the books.
The problem is and always has been that ME/CFS isn’t getting anything like its fair share of the research budget relative to disease burden. I think the argument needs to be more focused on that rather than implying that the government needs to find extra money, on top of its current budget for medical research, in order for ME/CFS to get more. In other words research into other conditions needs to get a smaller share of the total pot (whatever it may be) in order for us to get our fair share. As an advocate, I wouldn’t put it that way, but that is the mathematical reality.
Where there are gaps in the evidence base, we need to fill them. Where there are gaps in our understanding, we need to bring in experts. When our
most recent assessment of the economic impact of ME is over a decade old, and pre-dates the pandemic, are we really so surprised that our messaging isn’t breaking through?
I don’t disagree with this but the problem has always been finding the right experts who get the facts right. Experts who promote falsehoods or unevidence theories as facts, whether BPS or biomedical, are not helpful to our cause, but it can be very difficult for advocates and patients (including me) to accurately assess the reliability of non-BPS experts views, particularly when they have COIs pertaining to research or private practice.
My feeling is that we should be ultra conservative with estimates of prevalence and disease burden (as with promoting unevidenced theories an interventions). It’s tempting for advocates to inflate figures to emphasise the scale of the problem, but that risks undermining credibility. Even using the most conservative estimates of prevalence and costs, research funding is nowhere near proportional to disease burden relative to other conditions. That is the message I think we should be trying to convey.
Crucially, however, the strongest case for investing in ME isn’t only the economic cost of ignoring the issue. It’s making the case that investing in ME research, treatments and care will help the government solve problems it is already trying to solve.
From social care to welfare reforms, we need to think creatively about the government’s priorities. We need to make the case that investing in tackling ME can be part of the answer. Our new government has spoken about preventing societal challenges by intervening earlier. If that’s where the government is focused, that’s where our advocacy needs to be too.
The risk with this strategy is that there are BPS advocates who still claim to be able to solve these problems – like SW telling the DWP that benefits often make ME/CFS patients worse. For years New Labour had more money than it knew what do with but still funding for biomedical ME/CFS research was neglected, benefits for people were squeezed, and services were not fit for purpose.
If prevalence figures are inflated this gives the “experts” the opportunity to blow holes in those figures and convince the government that cutting benefits and rehabilitation will reduce costs and get people back to work.
I hope this doesn’t come across as too negative or critical. I am grateful to ThereForME and I think they have done some very positive work. I agree that Burnham may be receptive to calls to do more for people with ME/CFS – and ThereforME may be best placed to get the messaging across to him. I just hope that they will get the messaging right.
Writing this I’m mindful of Andy Burnham’s recent announcement that he will meet Archie Goodburn after his plea for more research into brain cancer:
https://www.bbc.co.uk/sport/articles/c5y4pp7q1wko
I don’t know the details well enough to know the strength of the case for increasing government investment into brain cancer research relative to investment into other medical conditions but I do recall that the government announced an extra £40 million investment in brain cancer research in the wake of Tessa Jowell’s death:
https://www.tessajowellbraincancerm...in-tumour-research-as-part-of-40m-investment/
I wonder if we and ThereForME can learn anything from Archie Goodman’s emotional appeal to Burnham. Unfortunately, with ME/CFS there is always the concern that if one individual’s appeal were to go viral, there is a high risk that the messaging would be unhelpful.
Maybe nothing of substance will come of Goodburn’s meeting with Burnham and/or maybe the lesson will simply be that sometimes random things happen which lead to memes, which may or may not result in just and substantive change.
[edited typos for clarity]